Table 2.
Challenges in managing individuals with TIDM.
COVID-19 induced Challenges | Effects on individuals with T1DM |
---|---|
Use of drugs, such as chloroquine and hydroxychloroquine | Higher risk of glycemic fluctuations and hypoglycemia |
Effect of ‘lock down’ | Lack of physical interaction with peers Reduced physical activity Increased screen time Intake of less healthy food Psychological stress Irregular sleep pattern |
Increased risk of DKA | Fear of contracting COVID-19 in a hospital and delay in seeking medical attention in case of an illness Difficulties accessing medical supplies |